Neuexcell Therapeutics
NeuExcell
United States · Founded 2021 · $25.0M raised
- Founded
- 2021
- Website
- neuexcell.com
- Total Funding
- $25.0M
- Last Round
- $15.0M Extension RoundMay 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.
About
NeuExcell Therapeutics is a clinical-stage gene-therapy company developing first-in-class treatments for neurodegenerative diseases. Its proprietary ATN Astrocytes To Neurons platform converts supporting glial cells into functional neurons at injury sites, with the aim of repairing damaged brain tissue. The company says it is advancing clinical trials in glioma, Alzheimer’s disease, and stroke, while evaluating the approach across additional neurological and ocular conditions.
Summary
Neuexcell Therapeutics is a Biotech company based in United States, founded in 2021. It has raised $25.0M in total across 2 rounds, most recently a $15.0M Extension Round in May 2023. Investors include Cowin Ventures.
Funding History
May 2023
Sign up to see all 2 events
Funding: Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neuexcell-therapeutics"><img src="https://indexed.vc/api/badge/company/neuexcell-therapeutics" alt="Neuexcell Therapeutics on Indexed.vc" width="260" height="76" /></a>